USPTO serial 79275292
ACTOLOG
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 26, 2021
- Examiner
- CALLOWAY, CHRISTINA DENISE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ACTOLOG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anna Kurian Shaw
Anna Kurian Shaw Hogan Lovells US LLP555 13th Street NWWashington, DC 20004UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical and pharmaceutical products, namely, oncological, anti-viral, anti-bacterial and autoimmunity pharmaceuticals and natural remedies; diagnostic reagents for medical purposes; synthetic peptides, binding proteins and living cells for medical, diagnostic and therapeutic purposes, in particular for cancer therapy | ACTIVE | — |
| 042 | Medical research and pharmacological research, namely, pharmaceutical research services; conducting research and clinical trials for others relating to the use and the engineering of t-cells and cancer treatment and therapy; scientific research in the field of chemistry, biochemistry and biology; scientific laboratory services, namely, biological, biochemical and chemical laboratory services; biological, biochemical and chemical analysis; medical and scientific research in the field of cancer diagnosis; scientific laboratory services, namely, biological and biochemical laboratory services; biological and biochemical examination services of specimens in the field of cancer treatment and diagnosis | ACTIVE | — |
| 044 | Medical services, namely, medical and pharmacological diagnosis of oncological, viral, bacterial, and autoimmune diseases and pharmaceutical services, namely, pharmaceutical compounding services for diagnosis and treatment of oncological, viral, bacterial, and autoimmune diseases; dispensing of pharmaceuticals, namely, providing medical supply for therapy, in particular supply of synthetic peptides, binding proteins and living cells for cancer therapy; medical diagnosis of cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Immatics Biotechnologies GmbH
- Other trademarks owned by Immatics Biotechnologies GmbH
- Other trademarks owned by Immatics Biotechnologies GmbH
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ACTOLOG
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 27, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 6, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 26, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 2, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 2, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 2, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 2, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 2, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 7, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 23, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 29, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 29, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 26, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 26, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 12, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 25, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 10, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 10, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 21, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 21, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 6, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 6, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 6, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 6, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 6, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 28, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 28, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 28, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 21, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 2, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 2, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 27, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 26, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2020 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Jan 31, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 30, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 22, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 11, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 7, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 26, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |